Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 14, 2026

BNP highlights bullish takeaways on agentic AI, growth in meetings with Salesforce, Workday, Snowflake

View original at seekingalpha.com
BNP highlights bullish takeaways on agentic AI, growth in meetings with Salesforce, Workday, Snowflake [Humans are using laptops and computers to interact with AI, helping them create, code, train AI, or analyze big data with fast, cutting-edge technology.] BNP Paribas highlighted key takeaways, including agentic AI, g…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Salesforce benefits from customer data and metadata context, resulting in better and more accurate outcomes for agentic AI

    60% confidence
  • Salesforce's marketing business will stabilize with new product functionality ramping, but Commerce is taking longer to demonstrate improvements due to competitive pressures and competing for R&D resources with AI areas

    60% confidence
  • LLM costs will weigh on gross margins, but Salesforce can secure volume discounts and expects costs per token to decline over time

    60% confidence
  • AI is an opportunity to increase accessibility of technologies to more business users by putting tools such as CoCo in people's hands

    60% confidence
  • Marketing business will stabilize with new product functionality ramping, but Commerce taking longer to improve due to competitive pressures and R&D resource allocation to AI

    60% confidence
  • Customers are finding value in using Snowflake's own coding tool for data operations because it is better at identifying patterns and context within Snowflake data while benefiting from Snowflake security and governance controls

    60% confidence
  • Snowflake is committed to maintaining product gross margins at 75% this year despite AI product gross margin headwinds

    60% confidence
  • Revenue growth acceleration expected in H2, potentially as early as Q3

    60% confidence
  • Company has not seen any mass piping of data out of Salesforce

    60% confidence
  • Margin targets may be lowered as company focuses on accelerating top-line growth and ensuring product portfolio relevance in agentic AI world

    60% confidence
  • Workday is returning to an organic product focus with a goal of delivering revenue growth acceleration, potentially resulting in improved Bookings growth in H2 FY'27 and revenue growth acceleration in FY'28

    60% confidence
  • LLM providers appear more focused on disrupting applications market than entering data platform market

    60% confidence
  • Some customers already replacing third-party point solution functionality by running workflows directly in Snowflake

    60% confidence
  • AI native is likely less than 2% of revenues but may have already helped drive the beat in Q4

    60% confidence
  • Snowflake is a key beneficiary of AI, which can help drive acceleration in demand for core platform and provides opportunities to extend use cases and reach through development simplification

    60% confidence
  • Integrated data model across HCM and Finance provides advantage as company increasingly sells the full suite

    60% confidence
  • AI native revenues are likely less than 2% of total revenues but may have already helped drive the Q4 beat

    60% confidence
  • Salesforce is doing all of the right things, but the share price will not likely react until Salesforce can 1) demonstrate stability in its core business and 2) demonstrate continued success and adoption of Agentforce along with Data Cloud

    60% confidence
  • Competition from Databricks is not new, and competitive fears appear to have died down from their peak a couple of years ago

    60% confidence
  • Data Cloud offering expected to ramp in second half, charged on consumption basis based on data amount

    60% confidence
  • Salesforce has not seen any mass piping of data out of Salesforce to date

    60% confidence
  • Customers are finding value in using Snowflake's own coding tool for data operations because it is better at identifying patterns and context within Snowflake data while benefiting from security and governance controls

    60% confidence
  • LLM companies appear more focused on disrupting the applications market rather than entering data platform market

    60% confidence
  • Marketing business will stabilize with new product functionality ramping, but Commerce taking longer to demonstrate improvements due to competitive pressures and R&D resource allocation

    60% confidence
  • Workday used to generate 60% of growth through existing customer base and 40% through new customers, but new customer growth has slowed in SLED, Healthcare, and retail sectors

    60% confidence
  • 27 years of operational CRM data embedded within systems of record provides advantage versus new competitors

    60% confidence
  • Workday is returning to organic product focus with goal of delivering revenue growth acceleration, potentially improving Bookings growth in H2 FY'27 and revenue growth acceleration in FY'28

    60% confidence
  • Some customers already replacing third-party point solution application functionality by running workflows directly in Snowflake

    60% confidence
  • Workday Data Cloud offering is expected to ramp up in the second half and will be charged on consumption basis based on amount of data

    60% confidence
  • If successful with new initiatives, second-half bookings should show improvement, potentially leading to revenue growth inflection in FY2027

    60% confidence

Data points we hold from this source

Snowflake Inc. · gross margin target75 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
BNP highlights bullish takeaways on agentic AI, growth in meetings with Salesforce, Workday, Snowflake — Source | Via News | Via News